Precision Optics Signs Production And Technology Licensing Agreement With A Surgical Robotics Company To Supply A Single-Use Cystoscopy Robotic Surgery Program
Portfolio Pulse from Benzinga Newsdesk
Precision Optics Corporation (POCI) has entered into a production and technology licensing agreement with an unnamed surgical robotics company. Under this agreement, POCI will supply components for a single-use cystoscopy robotic surgery program. This partnership could potentially increase POCI's production volume and revenue, as it taps into the growing market for surgical robotics and single-use medical devices.
December 04, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Precision Optics Corporation's new agreement to supply components for a single-use cystoscopy robotic surgery program may lead to increased production and revenue, tapping into the surgical robotics market.
The agreement positions POCI in a growing niche of the medical technology market, which is likely to increase demand for their products. As the provider for a single-use cystoscopy robotic surgery program, POCI may see a rise in production volume and revenue, assuming the surgical robotics company and the program gain market acceptance. The impact is scored positively due to the potential for increased business, but the confidence is not at the maximum because the financial details of the agreement and the identity of the surgical robotics company are not disclosed.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100